Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 32 | ECE2013 | Next issue

15th European Congress of Endocrinology

Symposia

Recent advances in the molecular study of endocrine tumours: microRNAs and more

ea0032s19.1 | Recent advances in the molecular study of endocrine tumours: microRNAs and more | ECE2013

TGF-β signaling and the microRNA machinery

Patocs Attila

The activin/transforming growth factor-β (TGF-β) is a family of evolutionary conserved polypeptides. Their role has been implicated in the regulation of embryonic development, reproduction and tumor formation.Related to tumorigenesis TGF-β signaling inhibits cell proliferation at multiple levels by i) inducing the expression of tumor suppressors p15Ink4b and p21Waf1, ii) repressing oncogenic factors such as c-MYC and ...

ea0032s19.2 | Recent advances in the molecular study of endocrine tumours: microRNAs and more | ECE2013

MicroRNAs in pituitary tumours

Fedele Monica

MicroRNA (miRNAs) are small non-coding RNA molecules that significantly impacted the understanding of cell biology in the last decade. They regulate the expression of 10–30% of all protein-coding gene, thus playing a crucial role in a wide range of biological and pathological processes. Consistently, aberrant miRNA expression has been implicated in numerous human diseases, including pituitary tumours. Different studies analysed the entire miRNA transcriptoma, by microarra...

ea0032s19.3 | Recent advances in the molecular study of endocrine tumours: microRNAs and more | ECE2013

MicroRNAs and gene expression patterns in adrenal tumours

Igaz Peter

MicroRNA and mRNA expression patterns have been investigated in several studies on adrenocortical tumours and in some reports on phaeochromocytomas. These studies are relevant from pathogenic, diagnostic and therapeutic aspects. Under- and overexpressed microRNAs representing tumour suppressor and oncogenic microRNAs have been reported that can be helpful in the diagnosis for differentiating benign and malignant adrenocortical tumours (e.g. miR-503-miR-511, miR-195, miR-483-5p...